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Assessment of Sleep Disturbances and Exhaustion
inMothers of ChildrenWith Atopic Dermatitis
Faustine D. Ramirez, BA; Shelley Chen, BS; SinéadM. Langan, FRCP, PhD; Aric A. Prather, PhD;
Charles E. McCulloch, PhD; Sharon A. Kidd, MPH, PhD; Michael D. Cabana, MD, MPH;
Mary-Margaret Chren, MD; Katrina Abuabara, MD, MA, MSCE
IMPORTANCE The well-being and development of children is strongly influenced by parents’
physical and psychosocial health. Data from small, clinic-based studies suggest that sleep loss
may be common in parents of children with atopic dermatitis (AD), but longitudinal
population-based studies are lacking.
OBJECTIVES To compare sleep disturbances over time betweenmothers of children with and
without AD and to determine whether these disturbances are associated with the child’s
disease severity and the child’s sleep disturbances.
DESIGN, SETTING, AND PARTICIPANTS In the ongoing Avon Longitudinal Study of Parents and
Children, all pregnant women residing in Avon, United Kingdom, with an expected delivery
date between April 1, 1991, and December 31, 1992, were recruited. Analyses for this study, a
secondary analysis of this cohort, were performed from September 2017 to September 2018.
Mother-child pairs were followed up with a time-varying measure of child AD activity and
severity and self-reportedmaternal sleepmeasures repeated at multiple time points between
child ages 6months and 11 years.
MAIN OUTCOMES ANDMEASURES Time-varying binarymeasures ofmaternal sleep duration
(<6 vs6 hours per night), difficulty falling asleep, early morning awakening, subjectively
insufficient sleep, and daytime exhaustion.
RESULTS The study followed up 13 988mother-child pairs from birth for a median duration
of 11 (interquartile range, 7-11) years. Among the cohort, 11 585 of 13 972mothers (82.9%)
were aged 21 to 34 years and 12 001 of 12 324 (97.4%) were of white race/ethnicity; 7220 of
13 978 children (51.7%) weremale. Sleep duration (adjusted odds ratio [AOR], 1.09; 95% CI,
0.90-1.32) and early morning awakenings (AOR, 1.16; 95% CI, 0.93-1.46) were similar between
mothers of children with and without AD. In contrast, mothers of children with ADweremore
likely to report difficulty falling asleep (AOR, 1.36; 95% CI, 1.01-1.83), subjectively insufficient
sleep (AOR, 1.43; 95% CI, 1.24-1.66), and daytime exhaustion (AOR, 1.41; 95% CI, 1.12-1.78)
independent of the child’s comorbid asthma and/or allergic rhinitis. For all measures, worse
child AD severity was associated with worse maternal sleep outcomes. Themagnitude and
significance of the associations were largely unchanged after adjustment for child sleep
disturbances.
CONCLUSIONS AND RELEVANCE Mothers of children with AD reported difficulty falling
asleep, subjectively insufficient sleep, and daytime exhaustion throughout the first 11 years
of childhood. However, child sleep disturbances did not fully explain maternal sleep
disturbances, and future research should investigate other mechanisms. In caring for children
with AD, clinicians should consider maternal sleep disturbances and caregiver fatigue.
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T he health, well-being, and development of children isstrongly influenced by the physical and psychosocialhealthof parents.1,2 Parents of childrenwith chronic ill-
ness, in particular, are susceptible to poor sleep, and im-
paired sleep has been associated with increased risks of can-
cer and cardiovascular disease,3 infectious illness,4 obesity,5
and premature mortality.6 Previous studies have found ma-
jor sleep impairments among parents of children with venti-
lator dependencyandcystic fibrosis,7,8 but fewstudies todate
have examined sleeppatterns amongparents of childrenwith
more common chronic illnesses.
Atopicdermatitis (AD) is oneof themost commonchronic
childhood conditions, affecting up to 1 in 5 children in devel-
oped countries.9 Atopic dermatitis is characteristically itchy,
and the symptom is often reported to be more severe at
night,10,11 causing nighttime awakenings secondary to itch-
ing and scratching.12,13 Toourknowledge, fewstudieshavedi-
rectly examined the association between parental sleep dis-
turbancesandseverityofchildADandaccountedforchildsleep
disturbances. Existing research is limited and has focused on
snapshots of small, clinic-based populations that are likely to
havemore severedisease than thegeneral population.12-15 Be-
cause theseverityandactivityofADcanvary throughoutchild-
hood, longitudinal studies canprovidebetter insight intohow
variations in the child’s disease activity and severity over time
affect parental sleep.
We aimed to determine whether mothers of children
with active AD have impaired sleep during the first 11 years
of childhood and whether these sleep disturbances are asso-
ciated with the child’s disease severity and the child’s sleep
disturbances.
Methods
Participants
Data for this study come from the ongoingAvonLongitudinal
StudyofParents andChildren (ALSPAC), a longitudinal, popu-
lation-basedbirth cohort in theUnitedKingdom.16,17 All preg-
nant women residing in Avon, United Kingdom, with an ex-
pected delivery date between April 1, 1991, and December 31,
1992, were recruited. The ALSPAC study enrolled a total of
14 541 pregnancies, which resulted in 14062 live births, of
which 13 988 infantswere alive at 1 year of age. For our analy-
ses,weuseddata from11649mother-childpairswhohaddata
on AD from at least 1 survey and sleep outcomes from at least
1 survey through age 11 years (83.3% of children who re-
mained alive at 1 year of age). The studywebsite contains de-
tails of all the data available through a fully searchable data
dictionary andvariable search tool.18 Data collection began in
1990 through 1992, and analyses for this study, a secondary
analysis of this cohort, were performed fromSeptember 2017
through September 2018. Ethical approval for the study was
obtained fromtheALSPACEthics andLawCommittee and the
Local Research Ethics Committees. The University of Califor-
nia, San Francisco declared the study exempt from the need
for institutional review board approval because all data ob-
tainedby investigatorswere fullydeidentified.Participantspro-
vided written informed consent at enrollment into the origi-
nal cohort.
Exposure
The primary exposure was a time-varying measure of active
AD in the child. Mothers were asked a standardized question
about flexural dermatitis at 10 timepoints between child ages
6 months and 11 years (6, 18, 30, 42, 57, 69, 81, 103, 128, and
140months): “Has your childhad an itchy, dry skin rash in the
joints and creases of his body (eg, behind the knees, elbows,
under the arms) in the past year?” This question is compa-
rable to that used in the large International Study of Asthma
and Allergies in Childhood (ISAAC).19 Children were catego-
rized ashaving activeAD if theirmother reported flexural der-
matitis at least twice, up to and including the timepoint being
considered.20-22 Disease severity was assessed at each time
point by asking mothers to categorize their child’s flexural
dermatitis over the past year as no problem, mild, moderate,
or severe.
Maternal Sleep Outcomes
Fivematernal sleep outcomesweremeasured at various time
points throughoutchildhood(Table 1). Sleepdurationwasmea-
suredbyastandardizedcategoricalquestion repeatedat5 time
points: “Howmany hours of sleep do you get altogether now
duringanaveragenight?” (Answerchoices: 1-3hours,4-5hours,
6-7 hours, and >7 hours). This variable was modeled as a di-
chotomous outcome—fewer than 6 hours per night com-
pared with 6 or more hours per night—because the National
SleepFoundation recommends 7 to9hours of sleep for adults
aged 26 to 64 years.23 Difficulty falling asleepwas assessed at
3 time points by the question, “Can you go to sleep alright?”
(Answerchoices:never/notveryoftenvsveryoften/often), and
early morning awakening was assessed at the same 3 time
points by the question, “Do you wake unusually early in the
morning evenwhen you haven’t beenwoken by your child or
family?” (Answer choices: very often/often vs never/not very
often). Subjectively insufficient sleepwas examined at 4 time
pointsbythequestion,“Doyoufeel thatyouaregettingenough
sleep?” (Answer choices: yes/no). Finally, daytime exhaus-
tion was measured at 7 time points by the question, “In the
Key Points
Question Domothers of children with atopic dermatitis
experience sleep disturbances, and to what extent are these
explained by child sleep disturbances?
Findings In this cohort study of 11 649mother-child pairs, sleep
disturbances were common amongmothers of children with
atopic dermatitis followed up from birth through age 11 years.
Having a child with atopic dermatitis was significantly associated
with impairedmaternal sleep quality, subjectively insufficient
sleep, and increased daytime exhaustion; however, child sleep
disturbances did not fully explain maternal sleep disturbances.
Meaning Clinicians caring for children with atopic dermatitis
should screen for maternal sleep disturbances and caregiver
fatigue.
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past month, how often have you felt exhausted?” (Answer
choices: almost always vs sometimes/not at all.)
Additional Covariates
Several potential confounders, mediators, and effect modifi-
erswere identified fromearlier literatureand incorporated into
a directed acyclic graph that was used to guide our modeling
strategy (eFigure in the Supplement). These factors included
child andmotherdemographic characteristics (child sex, child
age,mother’s race/ethnicity, andmaternal age at delivery), in-
dicators of socioeconomic status, household smoking expo-
sure,presenceof comorbidatopicdiseases in thechild (asthma
or allergic rhinitis), maternal sleep problems during preg-
nancy, maternal history of any atopic condition (AD, asthma,
or allergic rhinitis), and child sleep disturbances. Socioeco-
nomic statuswasmeasuredusingprenatal questionnaires col-
lected fromparents at study enrollment, including themoth-
er’s highest educational attainment, social class based on
occupation (highest of either parent), household crowding in-
dex (number of people living in the household divided by the
numberof rooms in thehouse), anda financialdifficulties score
assessing themother’s self-reported difficulty to afford food,
clothing,heating, rentormortgage, and itemsnecessary tocare
for her baby.Maternal sleepproblemsduring pregnancywere
assessed by prenatal questionnaire and based on questions
about difficulty falling asleep at 18 and 32 weeks’ gestation.
Time-varying covariates included child comorbid atopic
disease, household smoking exposure, and child sleepdistur-
bances. A child was determined to have comorbid atopic dis-
ease at each time point examined if his or her mother re-
ported asthma symptoms, allergic rhinitis symptoms, or both
at that time, on questions similar to those used in the ISAAC
studies.19Models also includedameasureofhousehold smok-
ing exposure, whichwas assessed bymaternal questionnaire
about the number of smokers living in the household at mul-
tiple timepoints throughoutchildhood.Finally, child sleepdis-
turbancesweremeasuredbyastandardizedquestionabout the
frequencyofnighttimeawakenings (dichotomizedat ≥1 awak-
eningper night) at 6 timepoints in early childhood (30, 42, 57,
69,81, and115months).Childnighttimeawakeningshavebeen
shown to be a validmeasure of AD-associated child sleep dis-
turbances throughout childhood.24
Missing Data
As has been described in detail elsewhere, there are both in-
termittent missing data and attrition (ie, loss to follow-up) in
the ALSPAC cohort.16 Multiple imputation was used to im-
pute missing exposure, outcome, and covariate data. Itera-
tive chained equations were used because most variables in
our models did not follow a normal distribution. Fifty im-
puted data sets were generated and used to repeat primary
analyses.
Statistical Analysis
Cross-sectional logistic regressionanalyseswereperformed to
compare maternal sleep outcomes between mothers of chil-
dren with and without AD at each time point. Longitudinal
analyses with repeated measures of the exposure, outcome,
andtime-varyingcovariateswere thenperformedusingmixed-
effectsmodelswith randomslopes and intercepts for each in-
dividual to estimate theparticipant-specific odds ratios (ORs)
for each of the maternal sleep outcomes. The minimally suf-
ficient adjustment setwasdeterminedusingourdirected acy-
clic graph (eFigure in the Supplement), and these factorswere
included inmultivariable models. Multivariable model 1 rep-
resents the fully adjustedmodel used to calculate the total as-
sociationof childADwithmaternal sleep, andmodel 2wasad-
ditionally adjusted for child sleep disturbances at each time
point to estimate the direct association of child AD with ma-
ternal sleep, independent of child sleep disturbances. Inter-
actions between child AD and child comorbid atopic disease
(asthma or allergic rhinitis), child age, child sex, and mater-
nal educational attainment were tested. All statistical analy-
ses were performed using Stata, version 14.2 (StataCorp).
Statistical significance was set at P < .05.
Results
The study samplewas composedof 13988mother-childpairs.
Among the children, 7220 of 13 978 (51.7%)weremale. Of the
mothers, 12 001 of 12 324 (97.4%) were of white race/
ethnicity, and 11 585of 13972 (82.9%)were aged21 to 34years.
The sample was followed for a median duration of 11 years
(interquartile range, 7-11 years). Mothers of children with AD
were more likely to have a personal history of atopy and a
higher educational attainment and social class (Table 2). The
annual period prevalence of child AD ranged from 16.4% to
21.0%, and 21.8% to 38.5%of childrenwith ADwere reported
to have moderate to severe disease at any given time point.
Overall, 4767 children of 13 988 (34.1%) met the definition of
having AD between 2 and 11 years of age.
The proportion of all mothers who reported each of the 5
sleep outcomes was fairly consistent across ages: 5% to 12%
reported sleeping less than 6 hours per night, 18% to 20% re-
ported early morning awakenings, 12% to 13% reported diffi-
Table 1. Maternal Sleep OutcomeMeasurements by Child Age
Outcome
Child Age, moa
21 33 47 61 73 85 110 134
Sleep duration x x x x x
Early morning awakening x x x
Difficulty falling asleep x x x
Subjectively insufficient sleep x x x x
Daytime exhaustion x x x x x x x
a An x indicates that the outcomewas
reported at the time point.
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Table 2. Cohort Characteristics
Characteristic No./Total No. (%)
Dermatitis, No. (%)
P ValuebNo AD (n = 5599) AD (n = 4767)a
Maternal Characteristics
White race/ethnicity 12 001/12 324 (97.4) 5039 (97.7) 4500 (97.9) .51
Age at delivery, y
≤20 1004/13 972 (7.2) 376 (6.7) 202 (4.2)
<.00121-34 11 585/13 972 (82.9) 4630 (82.7) 4061 (85.2)
≥35 1383/13 972 (9.9) 593 (10.6) 504 (10.6)
Maternal history of atopic conditionc 5659/12 454 (45.4) 2179 (42.0) 2318 (50.3) <.001
Household smoking exposured 3683/10 188 (36.2) 1661 (37.4) 1435 (33.7) <.001
Maternal highest educational attainmente
CSE/none 2504/12 412 (20.2) 1106 (21.3) 701 (15.2)
<.001
Vocational 1224/12 412 (9.9) 513 (9.9) 435 (9.4)
O level 4294/12 412 (34.6) 1860 (35.8) 1595 (34.6)
A level 2791/12 412 (22.5) 1149 (22.1) 1141 (24.8)
Degree 1599/12 412 (12.9) 563 (10.9) 736 (16.0)
Social classf
Unskilled 227/12 254 (1.9) 87 (1.7) 53 (1.2)
<.001
Partly skilled 920/12 254 (7.5) 381 (7.5) 274 (6.2)
Skilled manual 1666/12 254 (13.6) 717 (14.2) 502 (11.3)
Skilled nonmanual 3780/12 254 (30.8) 1601 (31.7) 1340 (30.2)
Managerial and technical 4566/12 254 (37.3) 1878 (37.1) 1779 (40.0)
Professional 1095/12 254 (8.9) 395 (7.8) 493 (11.1)
Financial difficulties quartileg
Lowest 4337/12 083 (35.9) 1819 (36.0) 1722 (38.5)
.06
Mild 3006/12 083 (24.9) 1272 (25.1) 1104 (24.7)
Moderate 2324/12 083 (19.2) 973 (19.2) 832 (18.6)
Highest 2416/12 083 (20.0) 995 (19.7) 817 (18.3)
Crowding indexh
≤0.5 5329/12 799 (41.6) 2085 (40.0) 2146 (46.7)
<.001
>0.5-0.75 4013/12 799 (31.3) 1644 (31.6) 1456 (31.7)
>0.75-1.0 2579/12 799 (20.2) 1111 (21.3) 788 (17.2)
>1.0 878/12 799 (6.9) 370 (7.1) 203 (4.4)
Maternal sleep problems during pregnancyi 4535/13 406 (33.8) 1886 (34.6) 1486 (31.5) .001
Child Characteristics
Male 7220/13 978 (51.7) 3022 (54.0) 2319 (48.7) <.001
White race/ethnicity 11 468/12 077 (95.0) 4812 (95.5) 4335 (95.6) .82
Asthma everj 3237/12 612 (25.7) 1078 (19.3) 1745 (36.6) <.001
Allergic rhinitis everi 1375/10 156 (13.5) 356 (8.1) 872 (20.2) <.001
Asthma or allergic rhinitis everi 3919/12 620 (31.1) 1300 (23.2) 2120 (44.5) <.001
Asthma and allergic rhinitis everi 693/12 620 (5.5) 134 (2.4) 497 (10.4) <.001
Abbreviations: AD, atopic dermatitis; CSE, certificate of secondary education.
a Children who ever reported AD through age 11 years (ie,2 reports of flexural
dermatitis). There were 3622 additional children with only 1 report of flexural
dermatitis.
b The χ2 test comparing mother-child pairs who never reported ADwith those
who ever reported AD through age 11 years.
c Includes AD, asthma, or allergic rhinitis.
dWhen child was aged 1.75 years.
e United Kingdom education levels: CSE (national school examinations at
16 years); vocational; O level (national school examinations at 16 years, higher
than CSE); A level (national school examinations at 18 years); and degree
(university degree or higher).
f Higher of either parent based on occupation.
g Financial difficulties score assessed themother’s self-reported difficulty to
afford food, clothing, heating, rent or mortgage, and items necessary to care
for her baby. The total score was divided into quartiles, increasing with greater
financial difficulties.
hDefined as the number of persons living in the household divided by the
number of rooms in the household.
i Defined as difficulty falling asleep often or very often at 18 or 32 weeks’
gestation.
j Defined as at least 2 reports of symptoms throughout childhood.
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culty falling asleep, 38% to 43% reported subjectively insuf-
ficient sleep, and 6% to 10% reported daytime exhaustion
during the first 11 years of their child’s life.
In unadjusted cross-sectional analyses comparing moth-
ers of childrenwith andwithoutADat individual timepoints,
resultswere generally consistent across all child ages (eTable 1
in the Supplement). In longitudinal analyses adjusted for con-
founders, sleep duration (adjusted OR [AOR], 1.09; 95% CI,
0.90-1.32) and early morning awakening (AOR, 1.16; 95% CI,
0.93-1.46)were similar formothers of childrenwith activeAD
compared with mothers of children who never reported AD
(Table 3). In contrast,mothers of childrenwith activeADwere
more likely to report difficulty falling asleep (AOR, 1.36; 95%
CI, 1.01-1.83), subjectively insufficient sleep (AOR, 1.43; 95%
CI, 1.24-1.66), anddaytimeexhaustion (AOR, 1.41; 95%CI, 1.12-
1.78) (Table 3). None of the interactions between childADand
childcomorbidatopicdisease (asthmaorallergic rhinitis), child
age, child sex, and maternal educational attainment were
statistically significant.
SubanalysisWith Child ADDisease Severity
When we examined the odds of maternal sleep disturbances
according to the child’s disease severity, we found larger ef-
fects among mothers of children with more severe disease
(Figure and eTable 2 in the Supplement). For maternal sleep
duration, we only found a statistically significant association
for mothers of children with severe disease, who had 61%
greater odds of reporting sleep duration less than 6 hours per
night (AOR, 1.61; 95% CI, 1.05-2.48). Although the odds were
also greater for early morning awakening and difficulty fall-
ing asleep, these odds did not reach statistical significance
(early awakening:AOR, 1.53; 95%CI, 0.96-2.45; difficulty fall-
ing asleep: AOR, 1.53; 95%CI, 0.90-2.58). An associationwith
daytime exhaustion and subjectively insufficient sleep was
stronger for mothers of children with severe disease (72%-
89% greater odds; subjectively insufficient sleep, OR, 1.89;
95%CI, 1.34-2.66; daytime exhaustion, OR, 1.72; 95%CI, 1.12-
2.64) and remained significant for those withmild tomoder-
ate disease (31%-39%greater odds;moderate disease: subjec-
tively insufficient sleep, OR, 1.31; 95% CI, 1.09-1.57; daytime
exhaustion, OR, 1.38; 95% CI, 1.06-1.81; mild disease: subjec-
tively insufficient sleep, OR, 1.34; 95% CI, 1.17-1.54; daytime
exhaustion, OR, 1.39; 95% CI, 1.12-1.74).
Subanalysis Accounting for Child Sleep Disturbances
Finally, we recalculated the odds of maternal sleep distur-
bances while controlling for child sleep disturbances at each
timepoint to examinewhether child sleepaccounted formost
of the associationbetween childADandmaternal sleep.Over-
all, we found that the magnitude and significance of the as-
sociationswas largelyunchangedafter adjusting for child sleep
disturbances in model 2 (Table 3, Figure, and eTable 2 in the
Supplement).
Multiple Imputation Results
Imputed data sets were used to repeat all primary analyses
(eTables 2 and 3 in the Supplement). Estimates using the im-
puted datawere slightly attenuated toward the null; however,
resultsremainedqualitativelysimilarandlargelyconsistentwith
those from the primary data.
Discussion
In a cohort of 11 649mother-child pairs followed up from the
child’s birth through age 11 years, sleep duration was similar
betweenmothers of childrenwith andwithout AD. However,
mothers of children with active AD reported subjectively in-
Table 3. Odds ofMaternal Sleep Disturbances Across Time Points AmongMothers of ChildrenWith Active Atopic Dermatitis (AD)
ComparedWithMothers of ChildrenWhoNever Reported ADa
Model
Odds Ratio (95% CI)
Sleep Duration
<6 h per Nightb
Early Morning
Awakeningc
Difficulty
Falling Asleepd
Subjectively
Insufficient Sleepe Daytime Exhaustionf
Unadjusted 0.92 (0.78-1.09) 1.27 (1.06-1.52) 1.17 (0.96-1.43) 1.45 (1.27-1.66) 1.38 (1.13-1.69)
Model 1 1.09 (0.90-1.32) 1.16 (0.93-1.46) 1.36 (1.01-1.83) 1.43 (1.24-1.66) 1.41 (1.12-1.78)
Model 2 1.06 (0.85-1.33) 1.15 (0.91-1.44) 1.33 (0.99-1.79) 1.42 (1.23-1.65) 1.43 (1.12-1.83)
a For each of thematernal sleep outcomes, results from an unadjusted and
2 separate adjustedmultivariable mixedmodels examining the association
between child active AD andmaternal sleep disturbances at multiple time
points are shown. Model 1 adjusted for child sex, child age, mother’s
race/ethnicity, child atopy (asthma and/or allergic rhinitis), household smoking
exposure, maternal educational attainment, social class, crowding index,
financial difficulties score, maternal sleep problems during pregnancy,
maternal atopy, andmaternal age at delivery. Model 2 adjusted for the same
variables as model 1 as well as child sleep disturbances at each time point.
Model 2 excluded the 134-month time point from analyses for the outcomes o
f sleep duration and daytime exhaustion because data on child sleep
disturbances were not available at that time.
bUnadjustedmodel: 10 691 individuals; mean (range) observations per
individual, 3.7 (1-5). Model 1: 8961 individuals; mean (range) observations per
individual, 3.7(1-5). Model 2: 8837 individuals; mean (range) observations per
individual, 3.1 (1-4).
c Unadjustedmodel: 10 449 individuals; mean (range) observations per
individual, 2.5 (1-3). Model 1: 8796 individuals; mean (range) observations per
individual, 2.5 (1-3). Model 2: 8771 individuals; mean (range) observations per
individual, 2.4 (1-3).
dUnadjustedmodel: 10 443 individuals; mean (range) observations per
individual, 2.5 (1-3). Model 1: 8794 individuals; mean (range) observations per
individual, 2.5 (1-3). Model 2: 8768 individuals; mean (range) observations per
individual, 2.4 (1-3).
e Unadjustedmodel: 10 546 individuals; mean (range) observations per
individual, 3.1 (1-4). Model 1: 8883 individuals; mean (range) observations per
individual, 3.1 (1-4). Model 2: 8831 individuals; mean (range) observations per
individual, 3.0 (1-4).
f Unadjustedmodel: 10 886 individuals; mean (range) observations per
individual, 5.1 (1-7). Model 1: 9061 individuals; mean (range) observations per
individual, 5.0 (1-7). Model 2: 9003 individuals; mean (range) observations per
individual, 4.4 (1-6).
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sufficient sleep, difficulty falling asleep, anddaytimeexhaus-
tion throughout the first 11 years of childhood. These find-
ings have important implications given that AD is one of the
most commonchronic childhood conditions and affects up to
20% of children of any age in industrialized countries.25
A strength of the present study is the use of a large pro-
spective, longitudinal, population-based cohort inwhich chil-
drenwere followed up frombirth formore than 10 years. The
fewstudies that have specifically examined the associationof
childADwithparental sleeprelative toparentsofchildrenwith-
out AD have been small, cross-sectional, and conducted in
clinic-based populations.12-15,26 In our study, onlymothers of
childrenwith severe diseasewere significantlymore likely to
report sleeping less than 6 hours per night. Similarly, Moore
and colleagues26 found that parents of children with moder-
ate to severeAD lost amedianof 39minutesof sleeppernight,
andMeltzer andBooster13 found that parents of childrenwith
AD were significantly more likely to report sleep duration of
less than 6 hours per night comparedwith parents of healthy
children.
Although impaired parental sleep is thought to be related
to the child’s nighttime awakenings,12,13,26 adjusting for child
sleep disturbances in our study did not change our conclu-
sions. This finding suggests thatmaternal sleep disturbances
maybeexplainedbyother factorsunrelated to thechild’s sleep
disturbances. Recent work from the pediatric psychology
literature in the setting of other chronic illnesses, including
asthma, ventilator dependency, and cystic fibrosis, has
supported caregiver stress and anxiety related to the child’s
condition as potential contributors to parental sleep
disruptions.7,8,13,27,28Other studieshave found that parents of
children with AD experience high rates of psychological dis-
tress and depression,12,29-31 which may explain some of their
sleep disturbances. Further research is needed to better un-
derstand the exact causes of these sleep disruptions and to
characterize their consequencesondaytime functioning,well-
being, andhealth outcomes in caregivers of childrenwithAD.
Maternal emotional and psychosocial well-being is inex-
tricably linked to the child’s health, development, and cogni-
tive and social functioning.1,2,32 In children with AD, chroni-
cally sleep-deprived, exhausted, or depressed caregiversmay
be lessequippedto implement time-consumingtreatment regi-
mens, regulate their child’s behavior, and help the child cope
with his or her illness.13,33 The American Academy of Pediat-
rics recommends that clinicians provide family-oriented care
thataddresses theneedsof theentire familyandpromotes fam-
ily functioning tooptimize childoutcomes.1 These recommen-
dations include screening for family circumstances that may
be associated with unfavorable outcomes for the well-being
of the child. Our results suggest that clinicians caring for chil-
dren with AD should screen for caregiver sleep disturbances
and fatigue, engage mothers in discussion about their emo-
Figure. Adjusted Odds for Sleep Disturbances Across Time Points AmongMothers of ChildrenWith Active Atopic Dermatitis (AD) by Disease Severity
vsMothers of ChildrenWhoNever Reported AD
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For each of the 5maternal sleep outcomes, results from 2 separate, adjusted,
multivariable mixedmodels examining the association between child active AD
andmaternal sleep disturbances at multiple time points are shown. Model 1 is
adjusted for child sex, child age, mother’s race/ethnicity, child atopy (asthma
and/or allergic rhinitis), household smoking exposure, maternal educational
attainment, social class, crowding index, financial difficulties score, maternal
sleep problems during pregnancy, maternal atopy, andmaternal age at delivery.
Model 2 is adjusted for the same variables as model 1 as well as child sleep
disturbances at each time point. Model 2 excluded the 134-month time point
from analyses of the outcomes of sleep duration and daytime exhaustion
because data on child sleep disturbances were not available at that time.
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tional health, and consider offering resources for psychoso-
cial support, particularly for mothers of children with more
severe disease. Cliniciansmay also consider formally screen-
ing mothers for sleep problems using the Pittsburgh Sleep
Quality Index,34 for depression using the Patient Health
Questionnaire-9,35,36 and for anxiety using the Generalized
Anxiety Disorder 7-item scale,37 all of which are well-
validated questionnaires. Additional research is needed to
understand how interventions targeted to both child AD and
maternal wellness can improve the entire family’s sleep.
Limitations
Several limitations warrant discussion, including the poten-
tial for selection bias due tomissing data and attrition, which
is inherent to all large-scale longitudinal studies. To address
this limitation, we performed multiple imputations and, re-
assuringly, found similar results. Another important limita-
tion relates to the possibility for misclassification bias be-
cause both exposure and outcome data were self-reported.
Although we cannot rule out the possibility of somemisclas-
sification, previous studies have found that self-report of AD
closely approximates physician assessment.38 Although it is
possible thatmotherswhoarechronicallyexhaustedmayhave
a tendency to reportmore severedisease in their child, the as-
sociations remained significant for mothers of children with
mild disease. In addition, the estimates ofmoderate to severe
diseasematchthoseofotherpopulation-basedstudies,24,39and
parent-reported disease severity has been shown to correlate
wellwith objective disease severitymeasures.40,41 In popula-
tion-basedstudiescomparingsurveyresponsesaboutsleepdu-
ration with objective measures, self-report tends to overesti-
mate total duration of sleep,42 which would bias our results
toward thenull. Anadditional limitation is that the sleepqual-
ity questions about difficulty falling asleep and early morn-
ing awakenings were not asked beyond the child’s fifth year.
Futurework should investigatewhether thesematernal sleep
quality disturbances persist into later childhood and adoles-
cence. The present study focused onmothers’ sleep because
mothers are often the primary caregivers; future research
should consider the role of fathers and other caregivers. Fi-
nally, although the cohort is fairly representativeof theUnited
Kingdom’s population,16 the extent to which our results are
generalizable to other populations is unclear.
Conclusions
This study’s results found that, throughout the first 11 years
of childhood, mothers of children with active AD experi-
encedmore difficulty falling asleep, subjectively insufficient
sleep, anddaytimeexhaustioncomparedwithmothersof chil-
dren without AD, and the child’s disease severity was associ-
ated with worsematernal sleep. Child sleep disturbances did
not fully explainmaternal sleep disturbances, and further re-
search is needed to better understand these mechanisms. In
caring for children with AD, clinicians should inquire about
caregiver sleep disturbances and fatigue and consider offer-
ing psychosocial support.
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